• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning's Departure

    3/4/25 5:18:00 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care
    Get the next $WGRX alert in real time by email

    TAMPA, FL, March 04, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ:WGRX) (the "Company"), a holding company for various existing and planned strategic businesses centered around healthcare technology and pharmaceutical services, today announced that Tim Canning, Chief Executive Officer, will be departing the company. Mr. Canning's leadership tenure helped guide Wellgistics Health through pivotal phases, and the Company expresses gratitude for his contributions.

    Brian Norton has been officially appointed as Chief Executive Officer. Mr. Norton has a proven track record of success and expertise in healthcare, technology, and pharmaceutical supply chain innovation and has led high-performing teams to accelerate market growth and revenue recognition. His ability to align on business strategy with operational execution has been instrumental in transforming organizations into industry leaders. His leadership comes at a pivotal time as the Company continues to streamline operations, expand market reach, and position itself as the industry's most advanced and efficient vertically integrated pharmaceutical supply chain solution.

    "The past year has been pivotal for Wellgistics Health, and I am proud of the work we have done in unifying multiple organizations, integrating key technologies, and laying the foundation for a scalable platform that supports pharmacies and patients across the U.S.," said Tim Canning. "Bringing the Company through its IPO was a significant milestone, and I have great confidence in the team to build on this momentum and drive Wellgistics Health into its next phase of growth."

    The Wellgistics Health Board of Directors expressed appreciation for Mr. Canning's leadership, particularly his role in navigating the Company's expansion including acquisitions of the Tech & Hub, Pharmacy and Distribution business units, and strategic realignment initiatives.

    "We thank Tim for his dedication to Wellgistics Health," said Suren Ajjarapu, Chairman of the Board. "His contributions have helped lay a foundation for long-term success. Moving forward, we are confident that Brian Norton's leadership, experience, and vision will drive the Company's next phase of operational excellence and innovation."

    "I am honored to step into the role of CEO at such a crucial moment," said Brian Norton. "Wellgistics Health is uniquely positioned to lead the transformation of how prescription drugs are distributed and dispensed. We are creating a tech-driven, vertically integrated supply chain that enables direct manufacturer-to-patient access. By eliminating intermediaries, enhancing transparency, and reducing costs, we are reshaping the industry and delivering long-term value for all constituents in the healthcare ecosystem along with our shareholders."

    Under Mr. Norton's leadership, Wellgistics Health will focus on enhancing operational efficiencies, optimizing sales and marketing strategies, advancing its technology roadmap, and remaining disciplined in executing on acquisition opportunities.

    About Wellgistics Health, Inc.

    Wellgistics Health, Inc. (NASDAQ:WGRX) is a holding company for existing and future planned operating companies centered around healthcare technology and pharmaceutical services. It seeks to be a micro health ecosystem, with a portfolio of companies consisting of a technology platform, pharmacy, and wholesale operations that provide novel prescription hub and clinical services. The Company is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. With the successful integration of its patient-centric approach and innovative healthcare applications, Company intends to shift the dynamic of pharmaceutical care to revolve around the patient for a wide range of therapeutic conditions by offering a full spectrum of integrated solutions as a result of leveraging the synergies of its business segments to address access, care coordination, dispensing, delivery, and clinical management of pharmaceutical products ranging from "specialty-lite" to general maintenance conditions. For more information, please visit the Company's website: https://wellgisticshealth.com/

    Forward-Looking Statements

    This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, the Company's statements regarding the Company's future direction, plans, and prospects. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and the completion of the initial public offering on the anticipated terms or at all, and other factors discussed in the "Risk Factors" section of the registration statement filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

    For more information, please contact:

    [email protected]



    Primary Logo

    Get the next $WGRX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WGRX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $WGRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DataVault AI and Wellgistics Health Announce Plans for PharmacyChain™ to Implement Manufacturer-to-Patient Blockchain-enabled Smart Contracts for the Prescription Drug Industry to Improve Efficiency and Patient Outcomes

    BEAVERTON, Ore., Oct. 22, 2025 (GLOBE NEWSWIRE) -- via IBN -- DataVault AI, Inc. ("DataVault") (NASDAQ:DVLT), leading the way in AI data experience, valuation, and monetization, and Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the two companies have entered into a non-binding letter of intent to implement manufacturer-to-patient blockchain-enabled smart contracts ("PharmacyChain™") into Wellgistics proprietary Technology and Physical infrastructure for the prescription drug industry. The goal of the partnership will be to seek to fully digitize t

    10/22/25 6:05:00 AM ET
    $DVLT
    $WGRX
    Semiconductors
    Technology
    Other Pharmaceuticals
    Health Care

    WGRX CEO Brian Norton to Go Live on Floorstocks YouTube — Unfiltered Market Talk at 1 PM EST

    NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ:WGRX), a growing force in pharmaceutical distribution and healthcare technology, will appear live on YouTube via the Floorstocks channel (@floorstocks) this Tuesday, July 22 at 1:00 PM EST. CEO Brian Norton will participate in an unfiltered discussion covering WGRX's recent momentum, stock performance, market outlook, and the company's strategy ahead. Floorstocks—the platform known for amplifying rising public companies—will host this live session, providing retail investors direct engagement. Why Tune In? Hear firsthand insight from CEO Brian Norton on the company's latest developmentsDeep dive into WGRX

    7/22/25 4:27:53 AM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    Floorstocks Releases Exclusive Nasdaq MarketSite Interview with Wellgistics Health Inc. (NASDAQ: WGRX)

    NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Floorstocks, a financial media platform with over 1.2 million active retail investors, has released an exclusive CEO interview filmed at the Nasdaq MarketSite with Brian Norton, CEO of Wellgistics Health Inc. (NASDAQ:WGRX). The full interview is now available on YouTube and Floorstocks.com, offering investors a front-row look at one of healthcare's most disruptive emerging growth companies. Watch the full interview on YouTube:https://youtu.be/gJJlbqd7Mv8 Also streaming at Floorstocks.com:https://www.floorstocks.com Hosted by market veteran Kenneth Polcari, the interview unpacks how Wellgistics is modernizing the $600+ billion U.S. prescription

    7/10/25 11:46:00 AM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    $WGRX
    SEC Filings

    View All

    Wellgistics Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Wellgistics Health, Inc. (0002030763) (Filer)

    10/22/25 8:41:18 AM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    SEC Form PRE 14C filed by Wellgistics Health Inc.

    PRE 14C - Wellgistics Health, Inc. (0002030763) (Filer)

    10/21/25 5:17:45 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    Wellgistics Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Wellgistics Health, Inc. (0002030763) (Filer)

    10/17/25 4:58:28 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    $WGRX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Fell Donald G.

    3 - Wellgistics Health, Inc. (0002030763) (Issuer)

    10/21/25 3:04:46 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    SEC Form 3 filed by new insider Lee Steven Dale

    3 - Wellgistics Health, Inc. (0002030763) (Issuer)

    10/14/25 4:45:31 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    Director Peterson Michael L gave a grant of 200,000 shares, decreasing direct ownership by 50% to 200,000 units (SEC Form 4)

    4 - Wellgistics Health, Inc. (0002030763) (Issuer)

    7/8/25 5:15:29 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    $WGRX
    Financials

    Live finance-specific insights

    View All

    Wellgistics Health Secures $50M ELOC facility for XRP Treasury Reserve & Real-Time Payments Infrastructure and other general ops

    Tampa, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ:WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the use of XRP, a blockchain-based digital asset, as both a treasury reserve and a real-time payments infrastructure-which management believes, upon successful commercialization, would make Wellgistics among the first publicly traded healthcare companies to deploy XRP in this manner. This XRP payment initiative is supported by Wellgistics Health's $50 million Equity Line of Credit (ELOC), the proceeds of which may be utilized to further develop and unlock programmable liquidity

    5/8/25 9:00:00 AM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    Wellgistics Health Secures $50M Credit Facility and Launches XRP-Powered Payment Initiative

    Tampa, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ:WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the use of XRP, a blockchain-based digital asset, as both a treasury reserve and a real-time payments infrastructure-which management believes, upon successful commercialization, would make Wellgistics among the first publicly traded healthcare companies to deploy XRP in this manner. This XRP payment initiative is supported by Wellgistics Health's $50 million Equity Line of Credit (ELOC), the proceeds of which may be utilized to further develop and unlock programmable liquidity

    5/8/25 7:05:00 AM ET
    $WGRX
    Other Pharmaceuticals
    Health Care